This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of dipeptidyl peptidase-4 (DPP-4) inhibitors, which are a class of drugs used to manage type 2 diabetes by regulating blood sugar levels. Its chiral nature and specific structural features make it valuable in creating enantiomerically pure compounds, ensuring high efficacy and reduced side effects in the final drug product. Additionally, its trifluorophenyl group enhances the metabolic stability and bioavailability of the resulting therapeutic agents.